Allergy Immunotherapy Market Size to Reach USD 5.12 Billion in 2028 | Top key Players Aimmune Therapeutics, Hollister Allergy, LETIPharma

Growing prevalence of various forms of allergies worldwide is a key factor driving the global market growth

The global allergy immunotherapy market size is expected to reach USD 5.12 billion in 2028 and register a revenue CAGR of 10.5% over the forecast period, according to the latest report by Reports and Data. Market revenue growth is spurred by factors such as increasing prevalence of different types of allergies globally – allergic rhinitis being one of the most common allergic diseases – and rise in R&D activities to develop more advanced and effective therapies. The American Academy of Allergy Asthma & Immunology claims that allergic rhinitis affects nearly 30% of the global populace. Growing prevalence of other allergic conditions including drug allergies, food allergies, and respiratory allergies such as allergic asthma further drives demand for allergy immunotherapy. Introduction of advanced immunotherapies for allergy, rising awareness of the availability of such treatments among people worldwide, increasing levels of environmental pollution, and changing lifestyles and eating habits are other important factors boosting the global market growth.

An allergy is a condition in which the body’s immune system responds abnormally to foreign substances called allergen, which typically do not harm the body. The most common allergens causing allergic reactions include certain types of food, pet dander, pollen, dust mites, or mold. Allergy immunotherapy, also referred to as hypo-sensitization or desensitization, is a medical treatment for different allergic reactions and involves administration of gradually increasing doses of particular allergens to eventually desensitize the immune system. Allergy immunotherapy is proven to be effective for conditions such as food allergies, animal allergies, allergic asthma, and allergic rhinitis. Different types of allergy immunotherapy include subcutaneous immunotherapy (also allergy shots), sublingual immunotherapy, oral immunotherapy, and transdermal immunotherapy.

Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/837

The global Allergy Immunotherapy market is expected to register significant growth throughout the forecast period. The pharmaceutical & healthcare sector has register significant revenue growth over the recent past. Technological advancements in the healthcare and medical sector, availability of latest tools and techniques, increasing investments in the healthcare sector and improving healthcare infrastructure are key factors boosting market growth. In addition, rising funds by several public and private sectors, high adoption of POC diagnosis and home care settings, is further fueling market growth.

The current pandemic has been very challenging for all industries including the healthcare and pharma sector. Shortage of medicines, vaccines and others healthcare facilities is expected to open lucrative growth opportunities for market players in going ahead.

Competitive Landscape:

The report offers detailed information about recent activities by market players, their market position, financial status, global standing, services and product portfolio along with license agreement. These key players are adopting various strategies such as partnerships, collaborations, merger and acquisitions, and joint ventures to gain robust footing in the market. These players are also investing in research and development activities to come up with enhanced materials and products.

Some Key Highlights from the Report:

• Among immunotherapy type segments, the subcutaneous immunotherapy (SCIT) segment is expected to account for the highest revenue share over the forecast period. One of the key factors contributing to growth of this segment is growing affordability and availability of allergy shots across hospital pharmacies, retail drug stores, and online pharmacies.

• Based on allergy type, the allergic rhinitis augment dominated other segments in terms of highest revenue contribution in 2020. Increasing cases of allergic rhinitis worldwide and rising adoption of advanced treatments are major factors boosting this segment’s growth.

• Among regional markets, Asia Pacific is the fastest-growing regional market for allergy immunotherapy and is projected to register a robust CAGR over the forecast period. Factors including rapid industrialization and urbanization, rising pollution levels, rapid climate change, and changing eating habits majorly account for market growth in the Asia Pacific region.

• Some of the top players in the global allergy immunotherapy market include Aimmune Therapeutics, Hollister Allergy, LETIPharma, Merck KGaA (Allergopharma), Stallergenes Greer, Allergy Therapeutics PLC, ALK-Abelló, HAL Allergy Group, Biomay AG, and Circassia.

Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/837

For the purpose of this report, the global allergy immunotherapy market is segmented on the basis of immunotherapy type, allergy type, product type, and region:

Immunotherapy Type Outlook (Revenue, USD Billion; 2018-2028)

• Subcutaneous Immunotherapy (SCIT)
• Sublingual Immunotherapy (SLIT)
• Oral Immunotherapy (OIT)
• Transdermal Immunotherapy (TDIT)
• Others

Allergy Type Outlook (Revenue, USD Billion; 2018-2028)

• Allergic Rhinitis
• Allergic Asthma
• Food Allergies
• Others

Product Type Outlook (Revenue, USD Billion; 2018-2028)

• SLIT Tablets
• Odactra
• Grastek
• Ragwitek
• Oralair
• Actair
• Others
• Oral
• Palforzia
• Others
• Injections
• Others

Region Outlook (Revenue, USD Billion; 2018-2028)

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key findings in the report:

• Information about key trends, technological developments, growing focus on drug discovery and investments in research and development activities

• Detailed insights about manufactures, product portfolios, pricing analysis and financial pricing

• Technological developments and detailed analysis in the volatile competitive landscape.

• New strategies adopted by new and emerging market players

• Estimation about manufactures, sales and import and export dynamics

Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/837

Thank you for reading the research report on global Allergy Immunotherapy market. Kindly contact us to know more about the customization feature and our team will offer the best suited report as per your requirement.

Read More Reports:-

Protein Binding Assays Market @ https://www.biospace.com/article/protein-binding-assays-market-size-to-reach-usd-710-8-million-in-2028/

Primary Care POC Diagnostics Market @ https://www.biospace.com/article/primary-care-poc-diagnostics-market-size-to-reach-usd-9-5-billion-in-2028-says-reports-and-data/

Stem Cell Banking Market @ https://www.biospace.com/article/stem-cell-banking-market-size-to-reach-usd-14-48-billion-in-2028-noted-reports-and-data-/

Contact Us:

John W
Head of Business Development
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.

This release was published on openPR.